摘要
背景:研究表明心血管危险因素与痴呆之间有一定的关联,但主要集中在阿尔茨海默病(AD)。 目的:我们通过评估心血管危险因素的存在与认知下降率之间的关系来加强这些工作。 (Mmse)和临床痴呆评分箱(cdr-sum)四种常见的痴呆亚型(AD,痴呆症和路易体痴呆(Dlb),额颞叶痴呆(Ftd)和血管性痴呆(Vad),以及a。 非精神错乱的老年人(正常)。 方法:采用随机截取的广义线性混合模型,考虑患者与中心两种痴呆亚型的相关性。 Eline认知评分、年龄和人口因素。评估的心血管危险因素包括体重指数、糖尿病、吸烟年数、心房颤动、高血压和最危险的高胆症。 erolemia. 结果:诊断为AD(n=1899)、DLB(n=65)、FTD(n=168)、VAD(n=13)或缺乏认知障碍(正常)(n=3583)的患者使用国家阿尔茨海默病协调中心的数据进行评估。 ING中心。心血管危险因素与选择性痴呆亚型有关,包括AD和FTD。使用MMSE和CDR-和,最近或活跃的高血压和高胆固醇血症是关联的。 AD患者的认知能力下降较慢,而较高的体重指数和吸烟时间则与FTD患者的认知下降速度较慢有关。然而,一些心血管疾病 相关因素显示,认知能力下降速度较快。
关键词: 阿尔茨海默病,路易体痴呆,额颞叶痴呆,神经心理测试,血管危险因素,体重指数。
Current Alzheimer Research
Title:Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes
Volume: 15 Issue: 11
关键词: 阿尔茨海默病,路易体痴呆,额颞叶痴呆,神经心理测试,血管危险因素,体重指数。
摘要: Background: Studies have shown select associations between cardiovascular risk factors and dementia, but mostly focused on Alzheimer’s Disease (AD).
Objective: We enhance these works by evaluating the relationship between the presence of cardiovascular risk factors and the rate of cognitive decline, measured using the Mini-Mental State Examination (MMSE) and Clinical Dementia Rating Sum of Boxes (CDR-SUM) on four common dementia subtypes (AD, dementia with Lewy bodies (DLB), frontotemporal dementia (FTD), and vascular dementia (VaD), as well as non-demented elderly individuals (normal)).
Method: We used generalized linear mixed models with random intercepts to account for correlation at the patient and center levels for each dementia subtype adjusting for time since initial visit, baseline cognitive score, age, and demographic factors. The cardiovascular risk factors evaluated included body mass index, diabetes, years of smoking, atrial fibrillation, hypertension, and hypercholesterolemia.
Results: Patients diagnosed with AD (n=1899), DLB (n=65), FTD (n=168), or VaD (n=13); or lacked cognitive impairment (normal) (n=3583) were evaluated using data from the National Alzheimer’s Coordinating Centers. Cardiovascular risk factors were associated with select dementia subtypes including AD and FTD. Using MMSE and CDR-SUM, recent or active hypertension and hypercholesterolemia were associated with a slower cognitive decline for AD patients, while higher body mass index and years of smoking were associated with a slower cognitive decline for FTD patients. However, several cardiovascular factors demonstrated associations with more rapid cognitive decline.
Conclusion: These results demonstrate disease specific associations and can provide clinicians guidance on predicted cognitive changes at the group level using information about cardiovascular risk factors.
Export Options
About this article
Cite this article as:
Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes, Current Alzheimer Research 2018; 15 (11) . https://dx.doi.org/10.2174/1567205015666180702105119
DOI https://dx.doi.org/10.2174/1567205015666180702105119 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Many Faces of Amyloid β in Alzheimers Disease
Current Molecular Medicine The Pivotal Role of Nitric Oxide: Effects on the Nervous and Immune Systems
Current Pharmaceutical Design Molecular Hydrogen as a Neuroprotective Agent
Current Neuropharmacology Efficacy of Enzyme Replacement Therapy in Fabry Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Current Pharmaceutical Design Editorial (Thematic Issue: Alzheimer’s Disease - Mechanisms, Drug Targets and Alternative Treatments)
Current Topics in Medicinal Chemistry Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
Current Alzheimer Research Physicochemical Strategies for Inhibition of Amyloid Fibril Formation: An Overview of Recent Advances
Current Medicinal Chemistry Protein Trafficking and Alzheimers Disease
Current Alzheimer Research Microdose Lithium Treatment Stabilized Cognitive Impairment in Patients with Alzheimer’s Disease
Current Alzheimer Research Therapeutic Potential of Cannabinoids in Schizophrenia
Recent Patents on CNS Drug Discovery (Discontinued) Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form
Current Alzheimer Research Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise
Current Psychopharmacology Therapeutic Advances in the Treatment of Alzheimer's Disease: Present and Future
Current Drug Therapy Aquaporin and Vascular Diseases
Current Neuropharmacology Detour Cum Distance Matrix Based Topological Descriptors for QSAR/QSPR Part-II: Application in Drug Discovery Process
Letters in Drug Design & Discovery Familial Alzheimers Disease Mutations in Presenilin 1 Do Not Alter Levels of the Secreted Amyloid-β Protein Precursor Generated by β-Secretase Cleavage
Current Alzheimer Research Hypoglycemia Induces Tau Hyperphosphorylation
Current Alzheimer Research Association of Smoking and Alcohol Drinking with Dementia Risk Among Elderly Men in China
Current Alzheimer Research